MedPath

Music, Arousal and Self-Injurious Behaviour: A 3-Stage Mediating Model For Children With Low Functioning Autism (Study 2)

Not Applicable
Conditions
ow Functioning Autism
Arousal (Cortisol)
Self-Injurious Behaviours
Low Functioning Autism
Mental Health - Autistic spectrum disorders
Registration Number
ACTRN12611001063909
Lead Sponsor
Curtin University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Male
Target Recruitment
30
Inclusion Criteria

Males aged between 6 to 11 years, Diagnosis of Autism and Intellectual Disability defined by a Full Scale Intelligence Quotient of 70 or below, the presence of Self-Injurious Behaviour, travel to school by bus, maintain ongoing treatment for the duration of the trial, no aversion to wearing earphones or having swabs taken for saliva collection as endorsed by primary carer(s).

Exclusion Criteria

Aversion to wearing headphones as stated by primary carer(s), not a school bus traveller, no primary carers to assist in transport or collection of saliva samples.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Self-Injurious Behaviour (Study 2)<br>Self-Injurious Behaviour (SIB) frequency will be recorded as a rate per minute measurement during the first 10 minutes of pre-test (Phase 1) and post-test (Phase 4)periods when the participant is exposed to video footage of a school bus ride.[A significant reduction in SIB frequency should occur for the music group from pre-test (Phase 1) to post test (Phase 4).];Salivary Cortisol (Study 2)<br>Salivary Cortisol from will be assessed from pre-test (Phase 1) and post-test (Phase 4) samples taken immediately after exposure to the footage of the school bus ride. Saliva samples will be collected via oral swabs and analysed during Phase 1 and Phase 4 to assess the effect of the music in reducing arousal.[A significant reduction in salivary cortisol levels should occur for the music group from pre-test (Phase 1) to post test (Phase 4).]
Secondary Outcome Measures
NameTimeMethod
il[Nil]
© Copyright 2025. All Rights Reserved by MedPath